跳至主要内容
临床试验/CTRI/2021/04/032809
CTRI/2021/04/032809尚未招募不适用

Effect of low- calorie sweetener - Sucralose (Sugar Free Natura) on cardio metabolic risk factors and Gut Microbiome among obese and adults with diabetes in India- A randomized trial

Zydus Wellness Ltd1 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2021年4月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
210
试验地点
1
主要终点
Assessing the change in body weight by replacing sugar (20-30g/day) with LCS-sucralose (pellet/powder/liquid form)

研究概览

简要总结

The study findings could further provide clear public health message on the use of LCS -Sucralose. To our knowledge this study will be the first of its kind in India that will bring out evidence on the effect of low-calorie sweetener sucralose on body weight, waist circumference, fasting blood glucose, HbA1c, insulin resistance, lipid profile, inflammatory markers and gut microbiome both among overweight adults.

研究设计

研究类型
Observational

入排标准

年龄范围
25.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • .Overweight/ obese participants (Asian Indian specific cut off) .Willing to follow study protocol .Willing to give informed consent .Willing to use LCS-sucralose for 12 weeks .Participants with features of metabolic syndrome, pre- diabetes.

排除标准

  • .Participants with known history or newly diagnosed diabetes .Any acute infections like viral fever, typhoid, cold, diarrhea, constipation last 1 month .Individuals with any disorders of liver, kidney, thyroid, or other endocrine diseases or other complications such as respiratory disorders, diabetes, cancer or heart attack and stroke that hinders the intervention .Individuals with any eating disorder .Participants undergoing any treatment or medications including antibiotics .Pregnant and lactating Women .Plans to relocate in the next 3 years.

结局指标

主要结局

Assessing the change in body weight by replacing sugar (20-30g/day) with LCS-sucralose (pellet/powder/liquid form)

时间窗: 12 weeks

次要结局

  • Assessing the effect of replacing sugars with low-calorie sweetener sucralose among over weight and obese adults on(Glycemic parameters-Fasting glucose, glycated haemoglobin (HbA1c), fasting insulin and HOMA IR)

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验